دورية أكاديمية
أعرض في EDS

Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims.

التفاصيل البيبلوغرافية
العنوان: Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims.
المؤلفون: Oberemok VV; Department of Molecular Genetics and Biotechnologies, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea. genepcr@mail.ru.; Department of DNA Technologies of Engineering Center, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea. genepcr@mail.ru., Andreeva OA; Department of Molecular Genetics and Biotechnologies, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea.; Department of DNA Technologies of Engineering Center, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea., Laikova KV; Department of Molecular Genetics and Biotechnologies, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea.; Department of DNA Technologies of Engineering Center, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea., Novikov IA; Department of Molecular Genetics and Biotechnologies, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea., Puzanova YV; Department of Molecular Genetics and Biotechnologies, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea.; Department of DNA Technologies of Engineering Center, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea., Kubyshkin AV; Department of DNA Technologies of Engineering Center, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea.
المصدر: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2022 Jun; Vol. 71 (5-6), pp. 521-536. Date of Electronic Publication: 2022 Apr 10.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9508160 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1420-908X (Electronic) Linking ISSN: 10233830 NLM ISO Abbreviation: Inflamm Res Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : Birkhäuser, c1995-
مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19 Vaccines*/therapeutic use , Pandemics*/prevention & control, Humans ; SARS-CoV-2 ; Vaccination
مستخلص: The vaccination rate worldwide has reached enormous proportions, and it is likely that at least 75% of the world's population will be vaccinated. The controversy is that, while people aged 65 and older suffer a significantly higher mortality rate from COVID-19, plans are being made to vaccinate young people under the age of 20. Equally thorny is the question of vaccinating people who already have antibodies to SARS-CoV-2, as well as B and T memory cells, because they contracted and survived the virus. The possible consequences of large-scale vaccination are difficult to predict, when some people do not have access to the vaccine at all and others have already received 3 doses of the vaccine. SARS-CoV-2 will circulate through the human population forever and continue to mutate, as viruses do. Therefore, in the coming years, the need to develop and use effective vaccines and medicines for the prevention and treatment of COVID-19 will remain urgent in view of the high mortality rate from this disease. To date, three vaccine platforms have been most used: adenoviral vector, inactivated, and mRNA. There is some concern about the side effects that occur after vaccination. Whether modern anti-coronavirus vaccines can raise the safety threshold, only time will answer. It is obvious that the pandemic will end, but the virus will remain in the human population, leaving behind invaluable experience and tens of millions of victims. This article is based on search retrieves in research articles devoted to COVID-19 mainly published in 2020-2021 and examines the possible consequences of the worldwide vaccination against SARS-CoV-2 and suggests that, while anti-coronavirus vaccines will not magically transport humanity to a non-pandemic world, they may greatly reduce the number of victims of the pandemic and help us learn how to live with COVID-19.
(© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
References: Lancet Infect Dis. 2022 Jan;22(1):56-63. (PMID: 34509185)
J Pers Med. 2021 Oct 02;11(10):. (PMID: 34683141)
Natl Sci Rev. 2021 Dec 04;9(2):nwab220. (PMID: 35211321)
Mol Ther. 2014 Dec;22(12):2118-2129. (PMID: 25027661)
China CDC Wkly. 2020 Jan 24;2(4):61-62. (PMID: 34594763)
Lancet Respir Med. 2021 Nov;9(11):1255-1265. (PMID: 34391547)
Front Immunol. 2020 Dec 23;11:602256. (PMID: 33424848)
BMJ. 2021 Sep 13;374:n2101. (PMID: 34518194)
Rev Med Virol. 2022 Jan;32(1):e2260. (PMID: 34043841)
Front Immunol. 2021 Feb 24;12:640093. (PMID: 33717193)
Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
Age Ageing. 2021 Feb 26;50(2):279-283. (PMID: 33320183)
Sci Rep. 2020 Oct 6;10(1):16642. (PMID: 33024235)
PLoS Biol. 2021 Apr 29;19(4):e3001237. (PMID: 33914735)
J Infect Dis. 2021 Feb 13;223(3):409-415. (PMID: 32692346)
Mol Ther. 2001 May;3(5 Pt 1):697-707. (PMID: 11356075)
Lancet. 2021 Jan 9;397(10269):99-111. (PMID: 33306989)
J Infect Dis. 2003 Apr 15;187(8):1257-63. (PMID: 12696005)
Lancet Infect Dis. 2021 Nov;21(11):1529-1538. (PMID: 34174193)
Nature. 2021 Sep;597(7876):318-324. (PMID: 34522017)
Science. 2020 Oct 30;370(6516):564-570. (PMID: 32912998)
Vaccine. 2011 Sep 2;29(38):6670-8. (PMID: 21745520)
Nat Rev Immunol. 2021 Oct;21(10):626-636. (PMID: 34373623)
NPJ Vaccines. 2021 Aug 5;6(1):97. (PMID: 34354082)
Int J Antimicrob Agents. 2020 Aug;56(2):106080. (PMID: 32634603)
Int J Infect Dis. 2021 Sep;110:258-260. (PMID: 34157386)
JAMA. 1973 May 21;224(8):1170-1. (PMID: 4739864)
Nature. 2020 Oct;586(7830):567-571. (PMID: 32756549)
J Occup Environ Med. 2016 Dec;58(12):1159-1166. (PMID: 27930472)
Nat Commun. 2020 Nov 18;11(1):5885. (PMID: 33208793)
Mol Ther. 2020 Nov 4;28(11):2303-2304. (PMID: 33065038)
J Virol. 2003 Aug;77(15):8263-71. (PMID: 12857895)
Nat Microbiol. 2020 Oct;5(10):1185-1191. (PMID: 32908214)
Cell. 2020 Jun 25;181(7):1489-1501.e15. (PMID: 32473127)
Prev Med. 2021 Sep;150:106694. (PMID: 34171345)
N Engl J Med. 2021 Apr 15;384(15):1412-1423. (PMID: 33626250)
Lancet. 2021 Feb 20;397(10275):642-643. (PMID: 33545098)
Vaccine. 2013 Apr 18;31 Suppl 2:B61-72. (PMID: 23598494)
Virology. 1996 May 1;219(1):220-7. (PMID: 8623532)
Nature. 2010 May 13;465(7295):161. (PMID: 20463719)
J Virol. 2003 Sep;77(18):10078-87. (PMID: 12941918)
Therapie. 2021 Jul-Aug;76(4):369-373. (PMID: 34083026)
Lancet Infect Dis. 2021 Jun;21(6):803-812. (PMID: 33548194)
Kidney Int. 2021 Aug;100(2):473-474. (PMID: 34081948)
Nat Commun. 2021 Jun 30;12(1):4043. (PMID: 34193870)
Nature. 2021 Aug;596(7870):109-113. (PMID: 34182569)
Pediatrics. 2001 May;107(5):1147-54. (PMID: 11331700)
Lancet Infect Dis. 2022 Jan;22(1):43-55. (PMID: 34480857)
Science. 2020 Sep 11;369(6509):1309-1312. (PMID: 32883884)
N Engl J Med. 2021 Sep 2;385(10):875-884. (PMID: 34233097)
Science. 1990 Mar 23;247(4949 Pt 1):1465-8. (PMID: 1690918)
J Virol. 2009 May;83(9):4386-94. (PMID: 19211743)
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):. (PMID: 35165203)
Lancet. 2021 Apr 17;397(10283):1459-1469. (PMID: 33844963)
JAMA. 2021 Jul 13;326(2):185-188. (PMID: 34106201)
Immunol Rev. 2000 Feb;173:89-97. (PMID: 10719670)
Mol Ther Methods Clin Dev. 2016 Apr 27;3:16030. (PMID: 27162933)
Sci Rep. 2021 Jun 15;11(1):12530. (PMID: 34131216)
Nucleic Acids Res. 2011 Nov;39(21):e142. (PMID: 21890902)
Lancet Reg Health Eur. 2021 Mar;2:100044. (PMID: 34173633)
Biomed J. 2021 Mar;44(1):18-30. (PMID: 33727051)
J Am Geriatr Soc. 2020 May;68(5):912-917. (PMID: 32212386)
Methods. 2022 May;201:15-25. (PMID: 33882362)
N Engl J Med. 2021 Feb 4;384(5):403-416. (PMID: 33378609)
Lancet Infect Dis. 2020 May;20(5):533-534. (PMID: 32087114)
Nat Rev Drug Discov. 2018 Apr;17(4):261-279. (PMID: 29326426)
Lancet. 2006 Feb 11;367(9509):475-81. (PMID: 16473124)
Science. 2021 Feb 5;371(6529):. (PMID: 33408181)
N Engl J Med. 2020 Dec 17;383(25):2427-2438. (PMID: 32991794)
Inflamm Res. 2020 Sep;69(9):801-812. (PMID: 32656668)
Arch Gerontol Geriatr. 2021 Sep-Oct;96:104487. (PMID: 34280598)
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):. (PMID: 33335073)
J Virol. 1985 Jun;54(3):711-9. (PMID: 3999192)
JAMA. 2020 May 12;323(18):1775-1776. (PMID: 32203977)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Immune Netw. 2021 Feb 15;21(1):e6. (PMID: 33728099)
PLoS One. 2012;7(4):e35421. (PMID: 22536382)
Vaccine. 2014 Nov 12;32(48):6377-89. (PMID: 24975812)
Nature. 2021 Sep;597(7875):166-168. (PMID: 34493845)
J Investig Med. 2021 Aug;69(6):1253-1255. (PMID: 34006572)
Hum Vaccin Immunother. 2016 Sep;12(9):2351-6. (PMID: 27269431)
Vaccine. 2020 Jul 22;38(34):5418-5423. (PMID: 32600908)
Science. 2020 May 29;368(6494):945-946. (PMID: 32385100)
J Virol. 2011 Jun;85(11):5565-70. (PMID: 21411537)
NPJ Vaccines. 2020 Sep 28;5:91. (PMID: 33083026)
Lancet Infect Dis. 2021 Feb;21(2):181-192. (PMID: 33217362)
Hum Vaccin Immunother. 2017 Dec 2;13(12):2837-2848. (PMID: 28604157)
Nature. 2021 Oct;598(7881):393-394. (PMID: 34650244)
Immunity. 2021 Feb 9;54(2):205-210. (PMID: 33513337)
NPJ Vaccines. 2021 May 21;6(1):77. (PMID: 34021159)
J Clin Med. 2021 Jun 15;10(12):. (PMID: 34203769)
Clin Immunol. 2021 Jan;222:108634. (PMID: 33217545)
Toxicol Rep. 2021;8:871-879. (PMID: 33898273)
J Virol. 2006 Nov;80(22):11241-54. (PMID: 16956941)
Nature. 2021 Jan 15;:. (PMID: 33452510)
N Engl J Med. 2020 Dec 31;383(27):2603-2615. (PMID: 33301246)
Front Immunol. 2020 Nov 06;11:589833. (PMID: 33240278)
Life (Basel). 2021 Mar 17;11(3):. (PMID: 33803014)
Nat Microbiol. 2020 Nov;5(11):1403-1407. (PMID: 32669681)
Eur J Epidemiol. 1988 Mar;4(1):12-9. (PMID: 3128450)
معلومات مُعتمدة: No. FZEG-2021-0009 Ministry of Science and Higher Education of the Russian Federation
فهرسة مساهمة: Keywords: COVID-19; Immunity; Immunological memory; Pandemic; Reinfection; SARS-CoV-2; Vaccine
المشرفين على المادة: 0 (COVID-19 Vaccines)
تواريخ الأحداث: Date Created: 20220410 Date Completed: 20220608 Latest Revision: 20231105
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8994861
DOI: 10.1007/s00011-022-01567-1
PMID: 35397666
قاعدة البيانات: MEDLINE
الوصف
تدمد:1420-908X
DOI:10.1007/s00011-022-01567-1